Kostas Athanasakis

Will be working towards the demonstration of the cost-effectiveness of MyPal.

Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825872.

Contact Info

Pantelis Natsiavas

Technical Coordinator
Institute of Applied Biosciences
Centre for Research and Technology Hellas
Thermi, 57001, Greece

pnatsiavas@certh.gr

Tel.: +30 2311 257608

Facebook Latest

MyPal

4 weeks ago

🎉We're honored to announce that the MyPal project has received the American Society of Hematology 2024 Abstract Achievement Award! 🏆 🔝This recognition at the 66th ASH Annual Meeting in San Diego highlights our commitment to improving the quality of life for #CLL and #MDS patients. Through the MyPal eHealth platform, we're empowering patients with electronic tools to report symptoms and enhance their care experience. 🏅Proud of our incredible team for this achievement! 💙🌍Εθνικό Κέντρο Έρευνας και Τεχνολογικής Ανάπτυξης | INAB - Institute of Applied Biosciences | Fraunhofer-Gesellschaft | Ίδρυμα Τεχνολογίας και Έρευνας | Lancaster University | Masaryk University | Karolinska Institutet | Università Vita-Salute San Raffaele | Medizinische Hochschule Hannover/ MHHnova | Fakultní nemocnice Brno | Universität des Saarlandes - Saarland University | European Association for Palliative Care - EAPC Vzw | ICPCN - International Children's Palliative Care Network | Πανεπιστήμιο Δυτικής Αττικής / University of West Attica#ASH24 #palliativecare #hematology #mypal #qualityoflife #ehealth ... See MoreSee Less

Photo

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Latest Tweet

MyPal-H2020 @h2020mypal ·

14 Nov

🎉Happy to announce that the #MyPal-ADULT study has been honored with the #ASH2024 Abstract Achievement Award at the 66th Annual Meeting of the @ASH_hematology

Proud of our team's dedication on improving #QoL for #CLL & #MDS patients through #ePROs💪

#hematology #PalliativeCare

Reply on Twitter 1857026446327247142 Retweet on Twitter 1857026446327247142 Like on Twitter 1857026446327247142 Twitter 1857026446327247142

Facebook
Twitter
Linkedin